» Articles » PMID: 17283063

Unusual Interplay of Two Types of Ras Activators, RasGRP and SOS, Establishes Sensitive and Robust Ras Activation in Lymphocytes

Overview
Journal Mol Cell Biol
Specialty Cell Biology
Date 2007 Feb 7
PMID 17283063
Citations 105
Authors
Affiliations
Soon will be listed here.
Abstract

Ras activation is crucial for lymphocyte development and effector function. Both T and B lymphocytes contain two types of Ras activators: ubiquitously expressed SOS and specifically expressed Ras guanyl nucleotide-releasing protein (RasGRP). The need for two activators is enigmatic since both are activated following antigen receptor stimulation. In addition, RasGRP1 appears to be dominant over SOS in an unknown manner. The crystal structure of SOS provides a clue: an unusual allosteric Ras-GTP binding pocket. Here, we demonstrate that RasGRP orchestrates Ras signaling in two ways: (i) by activating Ras directly and (ii) by facilitating priming of SOS with RasGTP that binds the allosteric pocket. Priming enhances SOS' in vivo activity and creates a positive RasGTP-SOS feedback loop that functions as a rheostat for Ras activity. Without RasGRP1, initiation of this loop is impaired because SOS' catalyst is its own product (RasGTP)-hence the dominance of RasGRP1. Introduction of an active Ras-like molecule (RasV12C40) in T- and B-cell lines can substitute for RasGRP function and enhance SOS' activity via its allosteric pocket. The unusual RasGRP-SOS interplay results in sensitive and robust Ras activation that cannot be achieved with either activator alone. We hypothesize that this mechanism enables lymphocytes to maximally respond to physiologically low levels of stimulation.

Citing Articles

WNK1-dependent water influx is required for CD4 T cell activation and T cell-dependent antibody responses.

Biggs OMay J, Vanes L, de Boer L, Lewis D, Hartweger H, Kunzelmann S Nat Commun. 2025; 16(1):1857.

PMID: 39984435 PMC: 11845700. DOI: 10.1038/s41467-025-56778-x.


The cell biology of HIV-1 latency and rebound.

Mbonye U, Karn J Retrovirology. 2024; 21(1):6.

PMID: 38580979 PMC: 10996279. DOI: 10.1186/s12977-024-00639-w.


targeted by H3K27me3 regulates myoblast proliferation and differentiation in mice and pigs.

Xiao L, Qiao J, Huang Y, Tan B, Hong L, Li Z Acta Biochim Biophys Sin (Shanghai). 2024; 56(3):452-461.

PMID: 38419500 PMC: 10984873. DOI: 10.3724/abbs.2024011.


Phosphorylation of RasGRP1 by Shc3 prevents RasGRP1 degradation and contributes to Ras/c-Jun activation in hepatocellular carcinoma.

Zhang X, Liu Y, Yang R, Guo Y, Yan M, Xiao Y Mol Cell Biochem. 2023; 479(9):2307-2321.

PMID: 37646951 DOI: 10.1007/s11010-023-04839-4.


Cutting Edge: Induced Loss of Rasgrp1 in Peripheral CD4+ T Cells of Conditional Rasgrp1-Deficient Mice Reveals an Essential Role for Rasgrp1 in TCR/CD28-Induced Ras-MAPK Signaling.

Chang Y, Manivannan P, Doosti A, Lapinski P, Chen D, Roose J J Immunol. 2023; 211(6):917-922.

PMID: 37566514 PMC: 10529702. DOI: 10.4049/jimmunol.2300138.


References
1.
Daniels M, Teixeiro E, Gill J, Hausmann B, Roubaty D, Holmberg K . Thymic selection threshold defined by compartmentalization of Ras/MAPK signalling. Nature. 2006; 444(7120):724-9. DOI: 10.1038/nature05269. View

2.
Boykevisch S, Zhao C, Sondermann H, Philippidou P, Halegoua S, Kuriyan J . Regulation of ras signaling dynamics by Sos-mediated positive feedback. Curr Biol. 2006; 16(21):2173-9. DOI: 10.1016/j.cub.2006.09.033. View

3.
Qian X, Esteban L, Vass W, Upadhyaya C, Papageorge A, Yienger K . The Sos1 and Sos2 Ras-specific exchange factors: differences in placental expression and signaling properties. EMBO J. 2000; 19(4):642-54. PMC: 305602. DOI: 10.1093/emboj/19.4.642. View

4.
Genot E, Cantrell D . Ras regulation and function in lymphocytes. Curr Opin Immunol. 2000; 12(3):289-94. DOI: 10.1016/s0952-7915(00)00089-3. View

5.
Matthews S, Rozengurt E, Cantrell D . Protein kinase D. A selective target for antigen receptors and a downstream target for protein kinase C in lymphocytes. J Exp Med. 2000; 191(12):2075-82. PMC: 2193207. DOI: 10.1084/jem.191.12.2075. View